NUZ 6.25% 22.5¢ neurizon therapeutics limited

Ann: Chief Executive Officer Appointment, page-71

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,075 Posts.
    lightbulb Created with Sketch. 192
    How do we know when the last participant in cohort 4 received their last dose?

    Then there will need to be testing and assessments at the completion for each participant?

    Once all the results have been received and assessments completed they will need to get the analysis of each set of data?
    Who would be writing the final report, the new CEO?
    I think it could take a bit of time to complete and might not be just pushing a button once the final participant completes dosing, we might not see the phase 1/2 final report till next month possibly?
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
-0.015(6.25%)
Mkt cap ! $109.4M
Open High Low Value Volume
24.0¢ 24.0¢ 22.5¢ $133.9K 573.8K

Buyers (Bids)

No. Vol. Price($)
3 303213 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 57592 2
View Market Depth
Last trade - 15.46pm 18/10/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.